Showing results (31-40 of 56) with videos related to
Sort By:
Pageof 6
JCO Clinical Cancer Informatics|July 16, 2020
HLA-Arena: A Customizable Environment for the Structural Modeling and Analysis of Peptide-HLA Complexes for Cancer ImmunotherapyDinler A Antunes, Jayvee R Abella, Sarah Hall-Swan, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 14, 2010
TGF-beta1 induces preferential rapid expansion and persistence of tumor antigen-specific CD8+ T cells for adoptive immunotherapyShujuan Liu, Tamara Etto, Tania Rodríguez-Cruz, et al.Frontiers in Oncology|June 24, 2024
Placental co-transcriptional activator Vestigial-like 1 (VGLL1) drives tumorigenesis via increasing transcription of proliferation and invasion genesHeather M Sonnemann, Barbara Pazdrak, Barbara Nassif, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytesAmelia Grover, Grace J Kim, Gregory Lizée, et al.Vaccines|September 28, 2023
Epidermal Growth Factor Receptor-Targeted Neoantigen Peptide Vaccination for the Treatment of Non-Small Cell Lung Cancer and GlioblastomaFenge Li, Huancheng Wu, Xueming Du, et al.Cancer Research|August 24, 2012
PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokinesWeiyi Peng, Chengwen Liu, Chunyu Xu, et al.Frontiers in Immunology|October 16, 2025
Mutation of conserved MHC class I cytoplasmic tyrosine affects CD8+ T cell priming, effector function, and memory responseYimo Sun, Yitao Tang, Priscilla Ortiz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2010
Transduction of tumor-specific T cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responsesWeiyi Peng, Yang Ye, Brian A Rabinovich, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 17, 2012
Agonistic antibody to CD40 boosts the antitumor activity of adoptively transferred T cells in vivoChengwen Liu, Carol M Lewis, Yanyan Lou, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 11, 2011
Antitumor activity mediated by CpG: the route of administration is criticalYanyan Lou, Chengwen Liu, Gregory Lizée, et al.Pageof 6